Repligen (RGEN) Tops Q2 EPS by 20c, Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $126.57 -4.13%
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.91, $0.20 better than the analyst estimate of $0.71. Revenue for the quarter came in at $207.6 million versus the consensus estimate of $189.6 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.13-$3.20, versus the consensus of $3.09. Repligen sees FY2022 revenue of $790-810 million, versus the consensus of $789 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AXT appoints Tracy Liu to its board of directors
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
